Expanded Access

Expanded access, also known as compassionate use, may be an option for a limited number of individuals with serious or life-threatening conditions, and who have exhausted all available medical options and who do not qualify for clinical trials. Tricida may provide access to its investigational drugs to patients who meet specific criteria through expanded access. Currently we do not have an expanded access program or compassionate use program for our investigational product. If we provide access through these programs in the future, the following are some of the general threshold criteria that must be met for Tricida to consider granting expanded access:

Process for requesting expanded access (compassionate use)

A qualified physician who believes that his/her patient may benefit from access to a Tricida investigational drug outside of a clinical trial should contact Tricida’s Medical Sciences team at: expandedaccess@tricida.com